KATHERINE BARRAGAN: Open Payments
NPI 1497525810 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,280 in 65 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $371 · 2025 $1,280
Food & beverage: $1,280
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $286 |
| AstraZeneca Pharmaceuticals LP | 6 | $165 |
| ABBVIE INC. | 8 | $144 |
| Exact Sciences Corporation | 4 | $74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $70 |
| Lilly USA, LLC | 3 | $58 |
| Axsome Therapeutics, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| Bausch Health US, LLC | 3 | $51 |
Products named: AIRSUPRA, Ozempic, The Cologuard Plus Collection Kit, Wegovy, XIFAXAN, UBRELVY, MOUNJARO, Kerendia.
Industry payments across NC — which companies pay providers there.
